Skip to content
Search

Latest Stories

GPhC announces pre-registration exam date

The General Pharmaceutical Council has announced that it will hold two separate sittings of the online pre-registration assessment in March next year.

The exams will take place at Covid-secure Pearson VUE test centres. There will be two sittings – each with different papers – and candidates will sit the two papers which make up the assessment at one of their local Pearson VUE centres on one day, either Wednesday March 17, or Thursday March 18 2021.


The application form will open in January. Candidates need to apply to sit the assessment through their myGPhC account and those who need any ‘reasonable adjustment’ can request for it using the same form.

The GPhC emphasises that although the way in which candidates will sit the assessment will be different this time, the types of questions used and the standard required to pass it will remain the same as in previous years.

Meanwhile, the Royal Pharmaceutical Society has welcomed the announcement, and is calling for further details to be clarified as quickly as possible.

"Trainees will be concerned about reasonable adjustments especially when there may be a last minute change such as a requirement to self-isolate at short notice," said RPS director for education Gail Fleming said.

"We're now urging GPhC to act quickly to publish the further details they have committed to providing. These are urgently needed to alleviate the ongoing concerns of those due to sit the assessment.

“We know how stressful it's been for trainees waiting for details of the exam, whilst working hard to support patients and the public during these difficult times.”

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less